Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community

May 2019 Formularies Update: Ninety-two (92) Medications Added to Medicare Plan Drug Lists


Article 6 of 92 in this Category
Prev   Next

May 2019 Formularies Update: Ninety-two (92) Medications Added to Medicare Plan Drug Lists
Published on 2019-05-20 16:10:08
Category: Monthly Formulary Changes


The May 2019 Medicare Part D plan formulary (drug lists) data includes the addition of 92 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 60 different drugs, many with multiple strengths.

New Generic Drugs Introduced: See our article https://Q1News.com/752.html for highlights of the new generics.

New Brand-Name Drugs Introduced
In addition, 13 new brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, ALYQ®, DEXEDRINE SPANSULE®, EXTINA®, FEMRING®, FIRDAPSE®, INBRIJA®, NUZYRA®, OLUX-E®, PERSERIS®, QNASL®, SEEBRI®, SYMPAZAN®, UTIBRON®.

What is the NDC?
The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 92 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 3
New Drug 31
New Drug and Strength 24
New Manufacturer 3
New Manufacturer and Delivery Form 3
New Manufacturer and Strength 10
New Manufacturer, Strength and Delivery Form 1
New Strength 17
Total New NDCs 70

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the 92 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
45802004475ACYCLOVIR 5% CREAM (g) [Zovirax]New Manufacturer, Strength and Delivery Form
47918089818AFREZZA 90-8 UNIT / 90-12 UNIT CART INHALNew Strength
31722093502ALBENDAZOLE 200 MG TABLET [Albenza]New Drug
66993001968ALBUTEROL HFA 90 MCG INHALER HFA AER AD [Ventolin HFA]New Drug
00093333406ALYQ 20 MG TABLETNew Drug
49884011701AMILORIDE HCL 5 MG TABLET [Midamor]New Drug
65757050003ARISTADA INITIO ER 675 MG/2.4 SUSER SYRNew Delivery Form
47781035803BUPRENORP-NALOX 12-3 MG SL FILM [Suboxone]New Manufacturer and Strength
47781035503BUPRENORP-NALOX 2-0.5 MG SL FILM [Suboxone]New Manufacturer and Strength
47781035603BUPRENORP-NALOX 4-1 MG SL FILM [Suboxone]New Manufacturer and Strength
47781035703BUPRENORP-NALOX 8-2 MG SL FILM [Suboxone]New Manufacturer and Strength
42858035340BUPRENORPHINE 7.5 MCG/HR PATCH Patch [Butrans]New Strength
45802063733CLOBETASOL EMOLLNT 0.05% FOAM [Olux-E]New Drug
00054024525CODEINE SULFATE 60 MG TABLETNew Manufacturer
23155019331COLISTIMETHATE 150 MG VIAL [Coly-Mycin M]New Drug
64896067410DEXEDRINE SPANSULE 10 MG CAPSULE ERNew Drug and Strength
64896067510DEXEDRINE SPANSULE 15 MG CAPSULE ERNew Drug and Strength
64896067310DEXEDRINE SPANSULE 5 MG CAPSULE ERNew Drug and Strength
17478089210DICLOFENAC 0.1% EYE DROPS [Voltaren]New Drug
68682010301DICLOFENAC SOD ER 100 MG TABLET ER 24H [Voltaren-XR]New Drug
00378811745DOXEPIN 5% CREAM (g) [Zonalon]New Drug
43547032506DOXYCYCLINE HYC DR 200 MG TABLET DR [Doryx]New Drug
00527145206DRONABINOL 10 MG CAPSULE [Marinol]New Drug and Strength
00527145006DRONABINOL 2.5 MG CAPSULE [Marinol]New Drug and Strength
00527145106DRONABINOL 5 MG CAPSULE [Marinol]New Drug and Strength
70362073030DVORAH 325-30-16 MG TABLET [Panlor]New Drug
00002237711EMGALITY 120 MG/ML SYRINGENew Manufacturer and Delivery Form
00378813650EXTINA 2% FOAMNew Drug
72495020105FEMRING 0.05 MG/DAY VAG RINGNew Drug and Strength
72495020210FEMRING 0.10 MG/DAY VAG RINGNew Drug and Strength
69616021106FIRDAPSE 10 MG TABLETNew Drug
00054042725FLUCYTOSINE 250 MG CAPSULE [Ancobon]New Drug and Strength
00054042825FLUCYTOSINE 500 MG CAPSULE [Ancobon]New Drug and Strength
68012000316GLUMETZA ER 1,000 MG TABLET TABERGR24HNew Strength
51862060650HALOBETASOL PROP 0.05% FOAM [LEXETTE]New Drug
10144034260INBRIJA 42 MG INHALATION CAP CAP W/DEVNew Drug
50102024023JASMIEL 3 MG-0.02 MG TABLET [Yaz]New Drug
68682085060LULICONAZOLE 1% CREAM (g) [LUZU]New Drug
69543037930POTASSIUM CL 20 MEQ PACKET [Klor-Con]New Manufacturer
00093774356MINOCYCLINE ER 105 MG TABLET ER 24H [Solodyn]New Manufacturer and Strength
00093774256MINOCYCLINE ER 80 MG TABLET ER 24H [Solodyn]New Manufacturer and Strength
00168027260MOMETASONE FUROATE 0.1% SOLUTIONNew Manufacturer and Delivery Form
65862005724NEVIRAPINE 50 MG/5 ML SUSP Oral Suspension [Viramune]New Drug
68462037629NORETH-ESTRAD-FE 1-0.02(24)-75 Chewable TABLET [Minastrin]New Manufacturer
71715000102NUZYRA 100 MG VIALNew Drug and Strength
71715000221NUZYRA 150 MG TABLETNew Drug and Strength
71715000223NUZYRA 150 MG TABLET-7 DAYNew Drug and Strength
71715000224NUZYRA 150 MG-7 DAY WITH LOAD TABLETNew Drug and Strength
00378814701OLUX-E 0.05% FOAMNew Drug
12496012001PERSERIS ER 120 MG SYRINGE KIT SUSER SYKTNew Drug and Strength
12496009001PERSERIS ER 90 MG SYRINGE KIT SUSER SYKTNew Drug and Strength
68682011102PIMECROLIMUS 1% CREAM (g) [Elidel]New Drug
63653117101PLAVIX 75 MG TABLETNew Strength
49884023183PRAZIQUANTEL 600 MG TABLET [Biltricide]New Drug
00254202980PREVIFEM TABLET [VyLibra]New Drug
00078097261PROMACTA 12.5 MG SUSPEN PACKET POWDER PACKNew Delivery Form
59310040606QNASL CHILDREN'S 40 MCG SPRAY HFA AER ADNew Drug and Strength
59310041012QNASL 80 MCG NASAL SPRAY HFA AER ADNew Drug and Strength
51991085401REPAGLINIDE 1 MG TABLET [Prandin]New Manufacturer and Strength
51991085501REPAGLINIDE 2 MG TABLET [Prandin]New Manufacturer and Strength
63402081560SEEBRI NEOHALER 15.6 MCG INHAL CAP W/DEVNew Drug
68462044718SEVELAMER HCL 800 MG TABLET [RenaGel]New Drug
66689034702SIROLIMUS 1 MG/ML SOLUTION [Rapamune]New Manufacturer and Delivery Form
10094021060SYMPAZAN 10 MG FILMNew Drug and Strength
10094022060SYMPAZAN 20 MG FILMNew Drug and Strength
10094020560SYMPAZAN 5 MG FILMNew Drug and Strength
71858013005TIROSINT-SOL 100 MCG/ML SOLUTIONNew Strength
71858013505TIROSINT-SOL 112 MCG/ML SOLUTIONNew Strength
71858014005TIROSINT-SOL 125 MCG/ML SOLUTIONNew Strength
71858010505TIROSINT-SOL 13 MCG/ML SOLUTIONNew Strength
71858014505TIROSINT-SOL 137 MCG/ML SOLUTIONNew Strength
71858015005TIROSINT-SOL 150 MCG/ML SOLUTIONNew Strength
71858015505TIROSINT-SOL 175 MCG/ML SOLUTIONNew Strength
71858016005TIROSINT-SOL 200 MCG/ML SOLUTIONNew Strength
71858011005TIROSINT-SOL 25 MCG/ML SOLUTIONNew Strength
71858011505TIROSINT-SOL 50 MCG/ML SOLUTIONNew Strength
71858012005TIROSINT-SOL 75 MCG/ML SOLUTIONNew Strength
71858012505TIROSINT-SOL 88 MCG/ML SOLUTIONNew Strength
64980040403TOREMIFENE CITRATE 60 MG TABLET [Fareston]New Drug
00169266211TRESIBA 100 UNIT/ML VIALNew Delivery Form
00254203080TRI-PREVIFEM TABLET [Trinessa]New Drug
50102023113TRI-VYLIBRA LO TABLET [Trinessa Lo]New Drug
00378240101TRIFLUOPERAZINE 1 MG TABLETNew Drug
63402068160UTIBRON NEOHALER 27.5-15.6 MCG CAP W/DEVNew Drug
00591385101VIGABATRIN 500 MG TABLET [Sabril]New Drug
00245055650VIGADRONE 500 MG POWDER PACKETNew Drug
43386008803VORICONAZOLE 50 MG TABLET [VFEND]New Strength
00378932032WIXELA 100-50 INHUB BLST W/DEV [Advair]New Drug and Strength
00378932132WIXELA 250-50 INHUB BLST W/DEV [Advair]New Drug and Strength
00378932232WIXELA 500-50 INHUB BLST W/DEV [Advair]New Drug and Strength
70515060215ZANAFLEX 2 MG CAPSULENew Manufacturer and Strength
70515060415ZANAFLEX 4 MG CAPSULENew Manufacturer and Strength



Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.


Article 6 of 92 in this Category
Prev   Next




Advertisement

Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs

Advertisement

Browse News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com


Ask a Pharmacist*
Have questions about your medication?

» Answers to Your Medication Questions, Free!
Available Monday - Friday
8am to 5pm MST
*A free service included with your no cost drug discount card.




Advertisement




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.